SENP5, a SUMO isopeptidase, induces apoptosis and cardiomyopathy

Eun Young Kim1, Yi Zhang2, Ilimbek Beketaev1

  • 1Center for Stem Cell Engineering, Department of Basic Research Laboratories, Texas Heart Institute at St. Luke's Episcopal Hospital, 6770 Bertner Avenue, MC 2-255, Houston, TX 77030, USA.

Insights

The desumoylation enzyme SENP5 is elevated in failing hearts, causing cardiac dysfunction and apoptosis by affecting mitochondrial dynamics. Targeting the SUMO conjugation pathway may offer new treatments for cardiomyopathy.

Area of Science:

  • Cardiovascular Biology
  • Mitochondrial Biology
  • Posttranslational Modifications

Background:

  • Cardiomyopathy is a major cause of heart failure, with over 50% of cases being idiopathic.
  • SUMOylation is a reversible posttranslational modification, but its role in heart disease is unknown.
  • Sentrin-specific proteases (SENPs) reverse SUMOylation.

Purpose of the Study:

  • To investigate the role of SENP5, a SUMO isopeptidase, in the pathogenesis of cardiac muscle disorders.
  • To determine if SENP5 overexpression in cardiomyocytes leads to cardiac dysfunction.

Main Methods:

  • Overexpression of SENP5 in murine cardiomyocytes (SENP5 transgenic, SENP5-Tg).
  • Assessment of cardiac function, cardiomyocyte proliferation, and apoptosis.
  • Analysis of SUMOylation of dynamin related protein (Drp1) and mitochondrial morphology.

Main Results:

  • SENP5 levels were significantly increased in human idiopathic failing hearts.
  • SENP5 overexpression in mice led to cardiac dysfunction, decreased cardiomyocyte proliferation, and increased apoptosis.
  • SENP5-Tg hearts showed reduced SUMOylation of Drp1, enlarged mitochondria, and impaired mitochondrial fission.
  • Overexpression of Bcl2 improved cardiac function in SENP5-Tg mice, indicating SENP5 targets mitochondrial function.

Conclusions:

  • SENP5 plays a critical role in the development of cardiac muscle disorders.
  • SENP5-induced desumoylation of Drp1 contributes to cardiomyopathy phenotypes.
  • The SUMO conjugation pathway is a potential therapeutic target for cardiomyopathy.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
8.6K
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
71
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.9K